Download the full report (130 p.)

More documents

Recommendations

Info

KCE Reports 74 Hyperbaric Oxygenation Therapy 94 57. Hailey D, Jacobs P, Perry D, Chuck A, Morrison A, Boudreau R. Overview of adjunctive hyperbaric oxygen therapy for diabetic foot ulcer. Review. Canadian Agency for Drugs and Technologies in Health (CADTH); 2007. Technology Overview no 25 Available from: http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/689 58. Rakel A, Huot C, Ekoe JM. Canadian Diabetes Association technical review: The diabetic foot and hyperbaric oxygen therapy. Canadian Journal of Diabetes. 2006;30(4):411-21. 59. Liu Z, Xiong T, Meads C. Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature. BMJ. 2006;333(7564):374. 60. Saunders PJ. Hyperbaric oxygen therapy in the management of carbon monoxide poisoning, osteoradionecrosis, burns, skin grafts, and crush injury. Int J Technol Assess Health Care. 2003;19(3):521-5. 61. Patterson J. Hyperbaric oxygen therapy for central retinal artery occlusion. Review. Bazian Ltd Wessex Institute for Health Research and Development (WIHRD); 2002. STEER: Succint and Timely Evaluated Evidence Reviews 2(15) Available from: 62. http://www.wihrd.soton.ac.uk/projx/signpost/welcome.htm Weinberger AWA, Siekmann UPF, Wolf S, Rossaint R, Kirchhof B, Schrage NF. [Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)-- Pilot study with 21 patients]. Klin Monatsbl Augenheilkd. 2002;219(10):728-34. 63. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11(8):1466-77. 64. Di Giorgio A, Sofo L, Ridolfini MP, Alfieri S, Doglietto GB. Pneumatosis cystoides intestinalis. Lancet. 2007;369(9563):766. 65. Van Meter KW. A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach. Undersea Hyperb Med. 2005;32(1):61-83. 66. Carson S, McDonagh M, Russman B, Helfand M. Hyperbaric oxygen therapy for stroke: a systematic review of the evidence. Clin Rehabil. 2005;19(8):819-33. 67. Moqadem K, Pineau G. Place de l'oxygénothérapie hyperbare dans la prise en charge de l'autisme. Review. Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS); 2007. AETMIS 07-01 Available from: http://www.aetmis.gouv.qc.ca/ 68. Pineau G, Moqadem K, Obadia A, Perron S. Place of hyperbaric oxygen therapy in the management of cerebral palsy. Review. Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS); 2007. AETMIS 07-01 Available from: 69. http://www.aetmis.gouv.qc.ca/ Medical Services Advisory Committee. Hyperbaric oxygen therapy (#1018-1020). Report. Medical Services Advisory Committee (MSAC); 2000. Available from: http://www.msac.gov.au 70. Bennett M, Kertesz T, Yeung P. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a systematic review of randomized controlled trials. J Laryngol Otol. 2005;119(10):791-8. 71. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006;129(1):174-81. 72. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. Oxford University Press; 2005. 73. McDonagh M, Carson S, Ash J, et al. Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke. Systematic review. Agency for Healthcare Research and Quality (AHRQ); 2003. Evidence Report/Technology Assessment No. 85 Available from: http://www.ahrq.gov/clinic/tp/hboxtp.htm
95 Hyperbaric Oxygenation Therapy KCE Reports 74 74. Mitton C, Hailey D. Hyperbaric oxygen treatment in Alberta. Systematic review. Alberta Heritage Foundation for Medical Research (AHFMR); 1998. HTA 8 Available from: http://www.ihe.ca/hta/hta_unit.html 75. Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante. Hyperbaric oxygen therapy in Quebec. Review. Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS); 2000. AETMIS 2000-3 RE Available from: 76. http://www.aetmis.gouv.qc.ca/ Hyperbare Sauerstofftherapie (HBO). 2000. 77. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Hyperbare Sauerstofftherapie bei der idiopathischen Femurkopfnekrose des Erwachsenen. 2007. 78. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Hyperbare Sauerstofftherapie bei Brandwunden. 2007. 79. Hailey D, Jacobs P, Perry D, Chuck A, Morrison A, Boudreau R. Adjunctive hyperbaric oxygen therapy for diabetic foot ulcer: an economic analysis. Systematic review. Canadian Agency for Drugs and Technologies in Health (CADTH); 2007. Technology Report No 75 Available from: http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/688 80. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: A double-blind randomized-controlled trial. European Journal of Vascular and Endovascular Surgery. 2003;25(6):513-8. 81. Guo S, Counte MA, Gillespie KN, Schmitz H. Cost-effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers. International Journal of Technology Assessment in Health Care. 2003;19(4):731-7. 82. Dempsey J, Hynes N, Smith T, Sproat J. A cost effectiveness analysis of hyperbaric therapy in osteoradionectosis. The Canadian Journal of Plastic Surgery. 1997;5(4):221-9. 83. Wheen L. The effectiveness and cost of oxygen therapy for diabetic foot wounds. Spums Journal. 1994;24(4):182-90. 84. Cianci P, Hunt TK. Long-term results of aggressive management of diabetic foot ulcers suggest significant cost effectiveness. Wound Repair & Regeneration. 1997;5(2):141-6. 85. Boykin JV, Jr., Crossland MC, Cole LM. Wound healing management: enhancing patient outcomes and reducing costs. Journal of Healthcare Resource Management.15(4):22. 86. Dolezal V. Diabetic foot and hyperbaric oxygen therapy. Prakticky Lekar. 2001;81(3):129-30. 87. Connor H. The economic impact of diabetic foot disease. In: Connor H, Boulton A, Ward J, editors. The foot in diabetes. Chichester: John Wiley 1987. 88. Marroni A, Oriani G, Wattell F. Cost benefit and cost efficiency evaluation of hyperbaric oxygen therapy. In: Oriani G, Marroni A, Wattell F, editors. Handbook in Hyperbaric Medicine: Springer Verlag, New York; 1996. p. 879-86. 89. Marroni A. Cout-efficacité de l'oxygénothérapie hyperbare. In: Wattel F, Mathieu D, editors. Traité de Médicine Hyperbare. Paris: Ellipses; 2002. p. 589-95. 90. Persels J. Economic aspects of hyperbaric oxygen therapy. In: Kindwall E, editor. Hyperbaric Medicine Practice. Arizona: Best Publishing Co; 1994. p. 97-118. 91. Rychlik R. Cost-effectiveness: relation of the treatment of diabetic foot lesion with hyperbaric oxygen therapy versus standard therapy. In: Wattel F, Mathieu D, editors. ECHM Consensus Conference on Hyperbaric Oxygen in the Treotment of Foot Lesions in Diabetic Patients. Marly-le-Roi (France): Glaxo Welcome; 1998. 92. Rychlik R, Kilburg A. The basics of health economics: an example from dermatology. Dermatology Psychosomatics. 2000;1:105-9. 93. Rychlik R, Kilburg A. Sozioökonomische Relevanz der adjuvanten Behandlung des diabetischen Fußes mit hyperbarem Sauerstoff versus Standardtherapie. Allgemeinarzt (eingereicht).
Page 1 and 2:
Hyperbaric Oxygen Therapy: a Rapid
Page 3 and 4:
Hyperbaric Oxygen Therapy: a Rapid
Page 5 and 6:
KCE Reports 74C Hyperbaric Oxygenat
Page 7 and 8:
KCE Reports 74C Hyperbaric Oxygenat
Page 9 and 10:
KCE Reports 74 Hyperbaric Oxygenati
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52: KCE Reports 74 Hyperbaric Oxygenati
Page 99 and 100: 91 Hyperbaric Oxygenation Therapy K
Page 101: 93 Hyperbaric Oxygenation Therapy K
Page 109 and 110: 101 Hyperbaric Oxygenation Therapy
Page 127 and 128: This page is left intentionally bla
Page 129: KCE reports 33 Effects and costs of
show all

Download the full report (130 p.)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?